Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FBLN3 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)

FBLN3 Origine: Humain Hôte: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD, Func, PI Active
N° du produit ABIN2719970
  • Antigène Voir toutes FBLN3 Protéines
    FBLN3 (Fibulin 3 (FBLN3))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    Transcript Variant 1
    Origine
    • 8
    • 4
    • 3
    • 1
    • 1
    Humain
    Source
    • 5
    • 4
    • 2
    • 2
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette FBLN3 protéine est marqué à la Myc-DYKDDDDK Tag.
    Application
    Antibody Production (AbP), Standard (STD), Functional Studies (Func), Protein Interaction (PI)
    Specificité
    Optimal preservation of protein structure, post-translational modifications and functions.
    Attributs du produit
    • Recombinant human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 1 (transcript variant 1) protein expressed in HEK293 cells.
    • Produced with end-sequenced ORF clone
    • Tested for bioactivity.
    Pureté
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
    Biological Activity Comment
    : 200 ng of recombinant purified EFEMP1-myc were added to cultured glioma cells (CNS-1 rat glioma cell line) for 6h, and cells were further processed for quantitative RT-PCR. Results showed increased expression of metalloproteases MMP2 and MMP9, in agreement with published results from Hu. et. al. (Mol. Cancer Res. (2009) 7:1756-1770) Data kindly provided by Dr. Mariano S. Viapiano, Ohio State University.
    Top Product
    Discover our top product FBLN3 Protéine
  • Indications d'application
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Protein-protein interaction
    In vitro biochemical assays and cell-based functional assays
    Commentaires

    The tag is located at the C-terminal.

    Restrictions
    For Research Use only
  • Concentration
    > 50 μg/mL
    Buffer
    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Nandhu, Hu, Cole, Erdreich-Epstein, Rodriguez-Gil, Viapiano: "Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas." dans: Cancer research, Vol. 74, Issue 19, pp. 5435-48, (2014) (PubMed).

  • Antigène
    FBLN3 (Fibulin 3 (FBLN3))
    Autre désignation
    Egf-Containing Fibulin-Like Extracellular Matrix Protein 1 (Efemp1) (FBLN3 Produits)
    Synonymes
    DHRD Protein, DRAD Protein, FBLN3 Protein, FBNL Protein, FIBL-3 Protein, MLVT Protein, MTLV Protein, S1-5 Protein, T16 Protein, EGF containing fibulin like extracellular matrix protein 1 Protein, EGF-containing fibulin-like extracellular matrix protein 1 Protein, epidermal growth factor-containing fibulin-like extracellular matrix protein 1 Protein, EFEMP1 Protein, Efemp1 Protein
    Sujet
    This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq, Nov 2009]
    Poids moléculaire
    52.7 kDa
    NCBI Accession
    NP_004096
    Pathways
    EGFR Signaling Pathway
Vous êtes ici:
Support technique